It’s hardly surprising that Johnson & Johnson has hired a small army of lawyers to defend it in the many product liability cases it’s facing, including the one that ended in a $1 billion verdict last week. What’s more interesting, however, is J&J’s approach to putting together its trial teams. The pharma giant keeps switching its lead counsel—a sign that J&J thinks that it should be winning these cases, lawyers say.
New Brunswick, New Jersey-based J&J is facing thousands of cases relating to the allegedly defective hip implant devices made by DePuy Orthopaedics Inc., which J&J acquired in 1998. J&J won the first so-called bellwether jury trial in October 2014, but the company has struggled since. In March, a federal jury in Dallas awarded a $502 million verdict to five plaintiffs, which was later reduced to about $150 million. And this month, the company was hit with a $1 billion punitive damages verdict, which is also sure to be reduced. A fourth case has been scheduled for September.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
